Pyridazinone derivatives

US9284300B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Dieter Dorsch · Ober-Ramstadt, DE
• Frank Stieber · Heidelberg, DE
• Oliver Schadt · Rodenbach, DE
• Andree Blaukat · Heilbad Heiligenstadt, DE

Key dates

• Filing date: Sep 25, 2014
• Grant date: Mar 15, 2016
• Expiry date: Sep 25, 2034

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2826
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I)and their uses as inhibitors of tyrosine kinases, in particular Met kinase, and their employment in methods for the treatment of tumors.